LF Process Indicator Tape for Steam Sterilization
Intertape Polymer Group · Decision date Feb 20, 2026
What did the FDA decide?
FDA records K260181 as a 510(k) premarket notification, with a decision dated Feb 20, 2026. The decision code SESE records a finding of substantial equivalence. This is a 510(k) clearance.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- General Hospital
- Decision date
- Feb 20, 2026
Regulatory record facts
- Identifier
- K260181
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Intertape Polymer Group
- Product code
- JOJ
- Decision code
- SESE
- Decision date
- Feb 20, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Indicator, Physical/Chemical Sterilization Process.
- Applicant
- Intertape Polymer Group
- Product code
- JOJ
- FDA device class
- 2
FDA decision timeline
K260181 received
Application receipt date recorded by FDA.
K260181 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code JOJ
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
Endox Test StripsK263267 | Ibt Scientific | 510(k) clearance | Oct 16, 2026 | FDA |
| Solventum US, LLC | 510(k) clearance | Sep 25, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Intertape Polymer Group
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Sarasota, FL
Sources and methodology
- Original FDA record: K260181
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 21, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records
